H-CYTE, INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 2nd, 2023 • H-Cyte, Inc. • Surgical & medical instruments & apparatus • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of February 21, 2023, by and between H-Cyte, Inc., a Nevada corporation (the “Company”), and the investors set forth on the signature pages affixed hereto (each, an “Investor” and, collectively, the “Investors”).
COMMON STOCK PURCHASE WARRANT H-CYTE, INC.H-Cyte, Inc. • March 2nd, 2023 • Surgical & medical instruments & apparatus • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________________ or their assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from H-Cyte, Inc., a Nevada corporation (the “Company”), up to ________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock 20% of the shares of Common Stock issuable upon conversion of the Convertible Promissory Note purchased by the Holder in the pursuant to the Securities Purchase Agreement between the Holder and the Company dated __________ pursuant to which the Holder purchased a Convertible Promissory Note (the “Convertible Promissory Note”). The purchase price of on
